USFDA designates Cipla’s Goa plant as ‘Official Action Indicated’
USFDA has classified Cipla’s Goa plant as ‘Official Action Indicated’. File. | Photo Credit: Special Arrangement Drug major Cipla on November 24 said the USFDA has classified its Goa plant as ‘Official Action Indicated’, impacting product approvals from the facility meant for the U.S. market. According to the U.S. Food and Drug Administration (USFDA) definition, […]
Continue Reading
